# Nurix Therapeutics, Inc.: Form 8-K, filed Apr 8, 2025

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2025-04-08
- Accepted by EDGAR: Apr 8, 2025, 16:02 ET
- Period: 2025-04-08
- Accession: 0001549595-25-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000154959525000053/nrix-20250408.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000154959525000053/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000154959525000053/nrix-20250408.htm

Filed Apr 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001549595-25-000053. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.